Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer

NCT03600701 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

NIH

Sponsor class

Conditions

Metastatic Lung Non-Small Cell Carcinoma
Recurrent Lung Non-Small Cell Carcinoma
Refractory Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8

Interventions

DRUG: Atezolizumab
PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
DRUG: Cobimetinib
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging

Sponsor

National Cancer Institute (NCI)